Loading...

Ontrak, Inc.

OTRKNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.10
$0.03(40.85%)

Ontrak, Inc. (OTRK) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Ontrak, Inc. (OTRK), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
-14.89%
14.89%
Operating Income Growth
15.36%
15.36%
Net Income Growth
8.71%
8.71%
Operating Cash Flow Growth
13.31%
13.31%
Operating Margin
-190.19%
190.19%
Gross Margin
57.60%
57.60%
Net Profit Margin
-274.20%
274.20%
ROE
-269.88%
269.88%
ROIC
-268.43%
268.43%

Ontrak, Inc. (OTRK) Income Statement & Financial Overview

View the income breakdown for Ontrak, Inc. OTRK across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$2.02M$3.15M$2.57M$2.45M
Cost of Revenue$1.27M$1.23M$975000.00$844000.00
Gross Profit$746000.00$1.92M$1.59M$1.61M
Gross Profit Ratio$0.37$0.61$0.62$0.66
R&D Expenses$1.41M$1.31M$1.22M$1.03M
SG&A Expenses$5.19M$4.97M$5.48M$4.63M
Operating Expenses$6.60M$6.28M$6.70M$5.65M
Total Costs & Expenses$7.87M$7.51M$7.68M$6.50M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$1.04M$800000.00$475000.00$6.25M
Depreciation & Amortization$558000.00$322000.00$171000.00$319000.00
EBITDA-$5.29M-$4.04M-$4.93M-$3.72M
EBITDA Ratio-$2.62-$1.28-$1.92-$1.52
Operating Income-$5.85M-$4.36M-$5.11M-$4.05M
Operating Income Ratio-$2.90-$1.39-$1.99-$1.65
Other Income/Expenses (Net)-$1.04M-$799000.00-$473000.00-$6.24M
Income Before Tax-$6.89M-$5.16M-$5.58M-$10.29M
Income Before Tax Ratio-$3.42-$1.64-$2.17-$4.20
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$6.89M-$5.16M-$5.58M-$10.29M
Net Income Ratio-$3.42-$1.64-$2.17-$4.20
EPS-$1.65-$0.95-$1.26-$2.21
Diluted EPS-$1.65-$0.95-$1.26-$2.21
Weighted Avg Shares Outstanding$5.52M$5.45M$4.42M$4.66M
Weighted Avg Shares Outstanding (Diluted)$5.52M$5.45M$4.42M$4.66M

Over the last four quarters, Ontrak, Inc. achieved steady financial progress, growing revenue from $2.45M in Q2 2024 to $2.02M in Q1 2025. Gross profit stayed firm with margins at 37% in Q1 2025 versus 66% in Q2 2024. Operating income totaled -$5.85M in Q1 2025, maintaining a -290% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$5.29M. Net income dropped to -$6.89M, with EPS at -$1.65. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;